Kidney transplant from donors with hepatitis B: A challenging treatment option

doi:10.4254/wjh.v13.i8.853

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7358)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

412

WORD

146

HTML

3610

Figures (1-2)

417

Sum=4585

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

539

Download

726

Sum=1265

Publishing Process of This Article

Item

Count

Browse

452

Download

1056

Sum=1508

Aug 27, 2021 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Aug 27, 2021; 13(8): 853-867
Published online Aug 27, 2021. doi: 10.4254/wjh.v13.i8.853

Open in New Tab Full Size Figure Download Figure

Figure 1 Risk factors of donor derived transmission of hepatitis B virus and proposed protective factors. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; Anti-HBc: Hepatitis B core antibody; Anti-HBs: Hepatitis B surface antibody.

Open in New Tab Full Size Figure Download Figure

Figure 2 Proposed management for several types of donor and recipient pairs according to the results of hepatitis B virus serology test and DNA markers. HBV: Hepatitis B virus; HBeAg: Hepatitis B e antigen; Anti-HBs: Hepatitis B surface antibody; HBIG: Hepatitis B immunoglobulin; HBsAg: Hepatitis B surface antigen.

Citation: Srisuwarn P, Sumethkul V. Kidney transplant from donors with hepatitis B: A challenging treatment option. World J Hepatol 2021; 13(8): 853-867
URL: https://www.wjgnet.com/1948-5182/full/v13/i8/853.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i8.853